IBM to develop pandemic software with WHO

  • 2 June 2006

IBM’s research division has announced that they are to collaborate with the World Health Organisation in supplying software to help combat and predict pandemics.

IBM have promised to develop two systems; an Interoperable Healthcare Information Infrastructure – a technology to help clinicians and researchers share information and health data on infectious diseases.

Big Blue will also develop an epidemiological modelling program that plugs into the data collected and projects how diseases can spread using geographic data and travel and migration patterns. Elements of both systems will be open-source.

Samuel J Palmisano, chief executive of IBM, said: "The threat of a pandemic is a definitively global phenomenon. Our response must be similarly global, and must reply – as with so many other major issues we face today – on open, collaborative innovation."

The two schemes are part of a collaborative initiative called ‘Project Checkmate’, in which IBM and the Scripps Institute, a non-profit biomedical research organisation based in San Diego, will conduct research into the way influenza viruses mutate. IBM will lend its BlueGene supercomputer to the project.

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

Digital Health’s monthly roundup of contracts and go lives

Digital Health’s monthly roundup of contracts and go lives

This roundup of contracts and go lives features multiple EPR contracts, including Liverpool University Hospitals NHS Foundation Trust. 
IBM awarded £160m to transform NHS App into ‘health companion’

IBM awarded £160m to transform NHS App into ‘health companion’

NHS England has awarded a contract worth more than £160m to IBM for the supplier to support the development of the NHS App.
UK Biobank to get access to GP patient data for research

UK Biobank to get access to GP patient data for research

The government will grant approval for UK Biobank researchers to access coded GP patient data for research purposes.